View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOD/DODOASHA RIN: 0720-AB85 Publication ID: Spring 2024 
Title: Expanding TRICARE Access to Care in Response to the COVID-19 Pandemic 
Abstract:

This rule finalizes an interim final rule that amended 32 CFR part 199 by: (1) adding freestanding End Stage Renal Disease (ESRD) facilities as a category of TRICARE-authorized institutional provider and modifying the reimbursement for such facilities; and (2) temporarily adopting Medicare’s New COVID-19 Treatments Add-on Payment (NCTAP).  The ESRD provisions are permanent, and the temporary NCTAP provisions expire at the end of the fiscal year in which the Secretary of Health and Human Services’ declared coronavirus disease 2019 (COVID-19) public health emergency ends.

 
Agency: Department of Defense(DOD)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 32 CFR 199   
Legal Authority: 5 U.S.C. 301    10 U.S.C. ch. 55   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Interim Final Rule  01/12/2023  88 FR 1992   
Interim Final Rule Effective  01/12/2023 
Interim Final Rule Comment Period End  03/13/2023 
Final Action  12/00/2024 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: Yes 
RIN Data Printed in the FR: No 
Agency Contact:
Ms. Sharon Seelmeyer
Medical Benefits and Reimbursement Section
Department of Defense
Office of Assistant Secretary for Health Affairs
16401 E Centretech Pkwy,
Aurora, CO 80011-9066
Phone:303 676-3690
Email: sharon.l.seelmeyer.civ@health.mil